{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:40:03Z","timestamp":1751499603858,"version":"3.41.0"},"reference-count":67,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Cervical cancer continues to be a major public health concern in India and other low- and middle-income countries. Tata Memorial Centre, India, has been at the forefront in providing treatment, developing best practice guidelines for low-cost efficacious interventions, conducting practice-changing randomized trials and engaging in regional and international collaborations for education and research in cervical cancer. This review summarizes how cervical cancer research and clinical care has evolved over the past two decades at the Tata Memorial Centre, right from testing low-cost public health screening of cervical cancers to the incorporation of the latest technological advancements and providing high-quality evidence for therapeutic management of cervical cancer. The various ongoing strategies for improving survival, toxicity reduction, translational research studies, educational activities and teaching programmes initiated by the Tata Memorial Centre at both national and international levels are discussed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_339_21","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T07:06:51Z","timestamp":1713251211000},"page":"319-328","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Contribution of Tata Memorial Centre, India, to cervical cancer care"],"prefix":"10.25259","volume":"154","author":[{"given":"Anuj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-17-20241212","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-17-20241212","first-page":"954","article-title":"Effective screening programmes for cervical cancer in low- and middle-income developing countries","volume":"79","author":"Sankaranarayanan","year":"2001","journal-title":"Bull World Health Organ"},{"key":"R3-17-20241212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.currproblcancer.2018.01.005","article-title":"Cancer cervix:Establishing an evidence-based strategy, an experience of a tertiary care centre in India","volume":"42","author":"Shrivastava","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"R6-17-20241212","doi-asserted-by":"crossref","first-page":"dju009","DOI":"10.1093\/jnci\/dju009","article-title":"Effect of VIA screening by primary health workers:Randomized controlled study in Mumbai, India","volume":"106","author":"Shastri","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R7-17-20241212","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/ijc.21220","article-title":"Screening for cervical cancer in India:How much will it cost a trial based analysis of the cost per case detected","volume":"117","author":"Legood","year":"2005","journal-title":"Int J Cancer"},{"key":"R8-17-20241212","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"R9-17-20241212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0019-509X.138165","article-title":"Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid","volume":"51","author":"Pimple","year":"2014","journal-title":"Indian J Cancer"},{"key":"R10-17-20241212","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/ijpvm.IJPVM_365_18","article-title":"Cervical cancer screening in low resource settings:Cytology versus HPV triage for VIA positive women","volume":"10","author":"Mishra","year":"2019","journal-title":"Int J Prev Med"},{"key":"R11-17-20241212","first-page":"1","article-title":"Menstrual pad, a cervical cancer screening tool, a population-based study in rural India","volume":"27","author":"Budukh","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R12-17-20241212","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions:A cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"key":"R13-17-20241212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pvr.2019.01.004","article-title":"Two-dose recommendation for human papillomavirus vaccine can be extended up to 18 years \u2013Updated evidence from Indian follow-up cohort study","volume":"7","author":"Basu","year":"2019","journal-title":"Papillomavirus Res"},{"key":"R14-17-20241212","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(15)00414-3","article-title":"Indian HPV Vaccine Study Group. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India:a multicentre prospective cohort study","volume":"17","author":"Sankaranarayanan","year":"2016","journal-title":"Lancet Oncol"},{"key":"R15-17-20241212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"R16-17-20241212","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ijrobp.2020.07.020","article-title":"FIGO classification 2018:Validation study in patients with locally advanced cervix cancer treated with chemo-radiation","volume":"108","author":"Raut","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-17-20241212","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/jnci\/91.6.500a","article-title":"New standard of care for cervical cancer sets stage for next questions","volume":"91","author":"McNeil","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R18-17-20241212","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3802\/jgo.2019.30.e97","article-title":"Adjuvant chemotherapy in locally advanced cervical cancer:The ceiling remains unbroken","volume":"30","author":"Gupta","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"R19-17-20241212","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","article-title":"Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix:A randomized clinical trial","volume":"4","author":"Shrivastava","year":"2018","journal-title":"JAMA Oncol"},{"key":"R21-17-20241212","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer:A randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"key":"R22-17-20241212","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1200\/JCO.2019.37.15_suppl.5503","article-title":"Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994","volume":"37","author":"Kenter","year":"2019","journal-title":"J Clin Oncol"},{"key":"R23-17-20241212","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/0973-1482.126480","article-title":"Treatment and outcome in cancer cervix patients treated between 1979 and 1994:A single institutional experience","volume":"9","author":"Shrivastava","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"R24-17-20241212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000447576","article-title":"Integrating chemotherapy in the management of cervical cancer:A critical appraisal","volume":"91","author":"Kumar","year":"2016","journal-title":"Oncology (Switzerland"},{"key":"R25-17-20241212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/ijc.IJC_428_17","article-title":"Locally advanced cervical cancer:A study of 5-year outcomes","volume":"55","author":"Chopra","year":"2018","journal-title":"Indian J Cancer"},{"key":"R26-17-20241212","first-page":"1","article-title":"Standard chemoradiation and conventional brachytherapy for locally advanced cervical cancer:Is it still applicable in the era of magnetic resonance-based brachytherapy?","volume":"4","author":"Mittal","year":"2018","journal-title":"J Glob Oncol"},{"key":"R27-17-20241212","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ygyno.2020.08.011","article-title":"Evaluation of outcomes in patients of cervical cancer with lower one third vaginal involvement:A single institutional experience","volume":"159","author":"Gurram","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R28-17-20241212","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/ijc.IJC_704_18","article-title":"Outcomes of locally advanced cervical cancer presenting with obstructive uropathy:An institutional audit","volume":"57","author":"Salunkhe","year":"2020","journal-title":"Indian J Cancer"},{"key":"R29-17-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2012.01.009","article-title":"Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India","volume":"17","author":"Rekhi","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"R30-17-20241212","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10552-007-9080-y","article-title":"Spectrum of HIV\/AIDS related cancers in India","volume":"19","author":"Dhir","year":"2008","journal-title":"Cancer Causes Control"},{"key":"R31-17-20241212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.radonc.2004.11.006","article-title":"HIV infection and invasive cervical cancers, treatment with radiation therapy:Toxicity and outcome","volume":"74","author":"Shrivastava","year":"2005","journal-title":"Radiother Oncol"},{"key":"R32-17-20241212","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/0973-1482.19588","article-title":"Monthly palliative pelvic radiotherapy in advanced carcinoma of uterine cervix","volume":"1","author":"Mishra","year":"2005","journal-title":"J Cancer Res Ther"},{"key":"R33-17-20241212","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1111\/ajco.13305","article-title":"Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasis","volume":"17","author":"Jain","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"R35-17-20241212","first-page":"1","article-title":"National cancer grid of India consensus guidelines on the management of cervical cancer","volume":"4","author":"Chopra","year":"2018","journal-title":"J Glob Oncol"},{"key":"R36-17-20241212","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/S0167-8140(18)30700-X","article-title":"Clinical outcome with dose escalation using IMRT in Cervical Cancer:A phase II randomized trial","volume":"127","author":"Gudi","year":"2018","journal-title":"Radiother Oncol"},{"key":"R37-17-20241212","doi-asserted-by":"crossref","first-page":"e001896","DOI":"10.1136\/bmjopen-2012-001896","article-title":"Protocol for a phase III randomized trial of image-guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late small bowel toxicity reduction after postoperative adjuvant radiation in Ca cervix","volume":"2","author":"Chopra","year":"2012","journal-title":"BMJ Open"},{"key":"R38-17-20241212","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER):A randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"key":"R39-17-20241212","doi-asserted-by":"crossref","first-page":"20180005","DOI":"10.1259\/bjr.20180005","article-title":"Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin","volume":"91","author":"Lewis","year":"2018","journal-title":"Br J Radiol"},{"key":"R40-17-20241212","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.radonc.2008.06.013","article-title":"A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy","volume":"89","author":"Cozzi","year":"2008","journal-title":"Radiother Oncol"},{"key":"R41-17-20241212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13014-020-1473-z","article-title":"Treatment planning comparison of volumetric modulated arc therapy employing a dual-layer stacked multi-leaf collimator and helical tomotherapy for cervix uteri","volume":"15","author":"Panda","year":"2020","journal-title":"Radiat Oncol"},{"key":"R42-17-20241212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.phro.2021.05.004","article-title":"Development and clinical validation of Knowledge-based planning for Volumetric Modulated Arc Therapy of cervical cancer including pelvic and para aortic fields","volume":"18","author":"Swamidas","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"R43-17-20241212","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.brachy.2020.08.019","article-title":"Brachytherapy in India:Learning from the past and looking into the future","volume":"19","author":"Kumar","year":"2020","journal-title":"Brachytherapy"},{"key":"R44-17-20241212","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.brachy.2021.08.012","article-title":"Low-dose-rate versus high-dose-rate intracavitary brachytherapy in cervical cancer - Final results of a phase I randomized trial","volume":"20","author":"Mahantshetty","year":"2021","journal-title":"Brachytherapy"},{"key":"R45-17-20241212","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijrobp.2017.09.009","article-title":"Radiobiological analysis of outcomes using external beam radiotherapy plus high dose-rate brachytherapy (4x7 Gy or 2x9 Gy) for cervical cancer in a multi-institution trial","volume":"99","author":"Hendry","year":"2017","journal-title":"Intl J Rad Oncol Biol Phys"},{"key":"R47-17-20241212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2019.08.004","article-title":"Vienna-II ring applicator for distal parametrial\/pelvic wall disease in cervical cancer brachytherapy:An experience from two institutions:Clinical feasibility and outcome","volume":"141","author":"Mahantshetty","year":"2019","journal-title":"Radiother Oncol"},{"key":"R48-17-20241212","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.brachy.2017.05.003","article-title":"Income generated by women treated with magnetic resonance imaging-based brachytherapy:A simulation study evaluating the macroeconomic benefits of implementing a high-end technology in a public sector healthcare setting","volume":"16","author":"Chakraborty","year":"2017","journal-title":"Brachytherapy"},{"key":"R50-17-20241212","first-page":"1","article-title":"Global challenges for cancer imaging","volume":"4","author":"Schlemmer","year":"2018","journal-title":"J Glob Oncol"},{"key":"R51-17-20241212","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5114\/jcb.2019.90448","article-title":"Patterns of cervical cancer brachytherapy in India:Results of an online survey supported by the Indian brachytherapy society","volume":"11","author":"Chatterjee","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"R52-17-20241212","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ijrobp.2018.05.080","article-title":"A Prospective comparison of computed tomography with transrectal ultrasonography assistance and magnetic resonance imaging-based target-volume definition during image guided adaptive brachytherapy for cervical cancers","volume":"102","author":"Mahantshetty","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R53-17-20241212","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2011.08.001","article-title":"Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix","volume":"102","author":"Mahantshetty","year":"2012","journal-title":"Radiother Oncol"},{"key":"R54-17-20241212","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1016\/j.ijrobp.2017.06.1330","article-title":"Transabdominal ultrasonography based high dose rate conformal intracavitary brachytherapy in cervical carcinoma","volume":"99","author":"Nayak","year":"2017","journal-title":"Intl J Radiat Oncol Biol Phys"},{"key":"R55-17-20241212","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brachy.2003.11.002","article-title":"A modified technique for high-dose-rate intracavitary brachytherapy in advanced cancer of the cervix","volume":"2","author":"Sharma","year":"2003","journal-title":"Brachytherapy"},{"key":"R56-17-20241212","first-page":"1","article-title":"External radiation and brachytherapy resource deficit for cervical cancer in India:Call to action for treatment of all","volume":"5","author":"Chopra","year":"2019","journal-title":"J Glob Oncol"},{"key":"R57-17-20241212","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ijrobp.2021.06.014","article-title":"Single application multifractionated image guided adaptive high-dose-rate brachytherapy for cervical cancer:dosimetric and clinical outcomes","volume":"111","author":"Mahantshetty","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R58-17-20241212","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2005.04.002","article-title":"Results of salvage radiotherapy after inadequate surgery in invasive cervical carcinoma patients:A retrospective analysis","volume":"63","author":"Saibishkumar","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R59-17-20241212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2004.02.044","article-title":"Recurrent squamous cell carcinoma of cervix after definitive radiotherapy","volume":"60","author":"Hong","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R60-17-20241212","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.brachy.2019.04.123","article-title":"Clinical outcomes of patients treated with template based high dose rate interstitial brachytherapy boost for gynaecological cancers- A retrospective analyses","volume":"18","author":"Mulye","year":"2019","journal-title":"Brachytherapy"},{"key":"R61-17-20241212","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/S0167-8140(16)31602-4","article-title":"OC-0353:EBRT and interstitial brachytherapy for recurrent vault carcinomas:Factors influencing the outcomes","volume":"119","author":"Engineer","year":"2016","journal-title":"Radiother Oncol"},{"key":"R62-17-20241212","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijrobp.2019.10.037","article-title":"MRI and PET guided interstitial brachytherapy for post-surgical vaginal recurrences of cervical cancer:Results of phase II study","volume":"106","author":"Chopra","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R63-17-20241212","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.brachy.2014.06.005","article-title":"Reirradiation using high-dose-rate brachytherapy in recurrent carcinoma of uterine cervix","volume":"13","author":"Mahantshetty","year":"2014","journal-title":"Brachytherapy"},{"key":"R64-17-20241212","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.brachy.2016.04.148","article-title":"Reirradiation with high-dose-rate brachytherapy in recurrent cervical cancer - An update","volume":"15","author":"Lewis","year":"2016","journal-title":"Brachytherapy"},{"key":"R65-17-20241212","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(17)31607-0","article-title":"Bevacizumab for advanced cervical cancer:Final overall survival and adverse event analysis of a randomized, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)","volume":"390","author":"Tewari","year":"2017","journal-title":"Lancet"},{"key":"R66-17-20241212","doi-asserted-by":"crossref","first-page":"20150054","DOI":"10.1259\/bjr.20150054","article-title":"Predictors of late bowel toxicity using three different methods of contouring in patients undergoing post-operative radiation for cervical cancer","volume":"88","author":"Chopra","year":"2015","journal-title":"Br J Radiol"},{"key":"R67-17-20241212","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijrobp.2013.11.214","article-title":"Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer:Results from a prospective study","volume":"88","author":"Chopra","year":"2014","journal-title":"Intl J Radiat Oncol Biol Phys"},{"key":"R68-17-20241212","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.brachy.2017.03.008","article-title":"Dose-volume correlation of cumulative vaginal doses and late toxicity after adjuvant external radiation and brachytherapy for cervical cancer","volume":"16","author":"Singh","year":"2017","journal-title":"Brachytherapy"},{"key":"R69-17-20241212","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/j.clon.2019.08.003","article-title":"A retrospective study of the dosimetric parameters and duodenal toxicity in patients with upper gastrointestinal and gynaecological cancers treated with radiation therapy","volume":"32","author":"George","year":"2020","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"R70-17-20241212","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/0971-5916.171276","article-title":"Humanpapillomavirus (HPV) genome status &cervical cancer outcome \u2013A retrospective study","volume":"142","author":"Das","year":"2015","journal-title":"Indian J Med Res"},{"key":"R71-17-20241212","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2017.11.034","article-title":"Impact of HPV 16\/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy \u2013A prospective observational study","volume":"148","author":"Mahantshetty","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R72-17-20241212","first-page":"S362","article-title":"Quantitative estimation of Hpv infection, viral load &its impact on clinical outcome in locally advanced cervical cancer treated with radical radio (chemo) therapy:An observational study","volume":"13","author":"Hotwani","year":"2017","journal-title":"J Can Res Therap"},{"key":"R73-17-20241212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2018.09.003","article-title":"Cancer stem cells, CD44, and outcomes following chemoradiation in locally advanced cervical cancer:Results from a prospective study","volume":"103","author":"Chopra","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_339_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:04:15Z","timestamp":1751497455000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/contribution-of-tata-memorial-centre-india-to-cervical-cancer-care-journey-of-two-decades\/"}},"subtitle":["Journey of two decades"],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_339_21","relation":{},"ISSN":["0971-5916"],"issn-type":[{"type":"print","value":"0971-5916"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}